Idanwo ti o sopọ mọ itọsọna · Alabọde Ipele

Recursion Pharmaceuticals AI adanwo

Test how Recursion turns cell images into phenomic fingerprints and compares perturbed cells with healthy references to prioritize candidates.

Jẹmọ itọsọna awọn ọnaRecursion Pharmaceuticals AI
Ibeere 1 ti 8

Kini iru data mojuto Recursion nlo lati kọ awọn awoṣe AI rẹ?

Awotẹlẹ gbogbo ibeere8 ibeere

Awọn idahun ati awọn alaye han bi o ṣe n mu ibeere naa.

  1. Kini iru data mojuto Recursion nlo lati kọ awọn awoṣe AI rẹ?
    • Awọn aworan maikirosikopu ti awọn sẹẹli eniyan rudurudu
    • Awọn igbasilẹ ilera eletiriki alaisan
    • Amuaradagba gara ẹya
    • Atokọ genomic ka nikan
  2. Kini ilana kikun Cell ṣe?
    • Awọn awọ ẹrọ lab fun titele
    • Awọn abawọn organelles pẹlu awọn awọ Fuluorisenti fun aworan ikanni pupọ
    • Kun èèmọ nigba abẹ
    • Ṣe afikun awọn ami omi AI si awọn aworan
  3. Kini idi ti Recursion ṣe atunṣe ipele ti o wuwo si data rẹ?
    • Lati compress awọn iwọn faili
    • Lati ṣe ailorukọ data alaisan
    • Lati yọ awọn ohun-ọṣọ imọ-ẹrọ kuro ki ifihan agbara ti ibi jẹ gaba lori
    • Lati yara gbigbe roboti
  4. Ile-iṣẹ wo ni o ṣe idoko-owo $ 50 million ni Recursion ni 2023?
    • Pfizer
    • Tesla
    • Amazon
    • NVIDIA
  5. Ni ọdun 2024, Recursion dapọ pẹlu ile-iṣẹ iṣawari oogun AI wo?
    • Exscientia
    • Insitro
    • Isomorphic Labs
    • DeepMind
  6. Kini idanwo gidi-aye bọtini ti Syeed Recursion?
    • Nọmba ti awọn aworan ti ipilẹṣẹ
    • Boya awọn oludije ti ipilẹṣẹ AI ṣaṣeyọri ninu awọn idanwo ile-iwosan eniyan
    • Robot iyara
    • Awujọ media igbeyawo
  7. What does Recursion's phenomics pipeline produce from images of perturbed cells?
    • A complete clinical diagnosis for each patient
    • A three-dimensional protein structure for every compound
    • Numerical fingerprints that summarize cellular morphology
    • A direct measurement of a drug's approval probability
  8. How can Recursion use a phenomic fingerprint to nominate a possible drug hit?
    • Select the compound with the brightest microscope image in every assay
    • Choose the compound that changes no measured cell features
    • Assume a similar fingerprint proves clinical effectiveness in people
    • Look for a compound that shifts disease-altered cells toward a healthy reference state